A phase I trial of PfCSP DNA/MVA-CSO prime/boost vaccine in Mampong, Ghana.
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 27 Sep 2007
At a glance
- Drugs Malaria DNA vaccine VCL-2510 (Primary) ; Malaria vaccine
- Indications Falciparum malaria
- Focus Adverse reactions; Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 08 Dec 2006 New trial record.